Jim Cramer was not selling stocks in Tuesday’s wreckage. Here is why he stood firm

Jim Cramer was not selling stocks in Tuesday’s wreckage. Here is why he stood firm


Jim Cramer explains why he stayed the course during Tuesday's market plunge and did not sell

CNBC’s Jim Cramer said he was not marching in the parade of sellers Tuesday, as the major U.S. stock indexes on Tuesday recorded their worst one-day drop-off since June 2020.

“Look, I cannot blame anyone for panicking after we got still one more red-hot consumer price index number, showing that non-commodity inflation has yet to peak,” the “Mad Money” host said, acknowledging it was a “horrendous day no matter how you slice it.”

However, Cramer said investors rarely make wise decisions when they panic, so it’s important for long-term investors to keep their focus on the big picture on a day like Tuesday, when only five stocks in the S&P 500 finished in positive territory.

“I’m not saying you need to buy something here yet,” Cramer said, noting his Charitable Trust, the portfolio used by the CNBC Investing Club, bought just one stock amid the wreckage. “We know a bounce may not directly be in the offing,” he added. “But the bottom line? We sure weren’t selling.”

Cramer said the reason he didn’t sell rests in his belief that the market entered Tuesday’s session in a no-win position. On the one hand, he said he thinks bearish investors overreacted to August’s CPI report, stressing it was only slightly worse than consensus estimates even though it likely guarantees a third-straight aggressive interest rate hike from the Federal Reserve next week.

At the same time, Cramer said if the inflation data had, hypothetically, come in slightly better than expected, bearish investors would’ve found a way to spin the narrative toward a focus on whether the Fed was being too aggressive with price pressures already easing.

Cramer said he’s choosing to look past that “false dichotomy.” Instead, he said he believes that even after the August CPI report it remains possible for the U.S. central bank to “thread the needle” and raise interest rates to control inflation without sending the economy into a downturn akin to the Great Recession. “This is not 2007 or 2008,” he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More